PPARG and prostate cancer: There was weak evidence for an association of genetically proxied PPARG perturbation with an elevated risk of prostate cancer (OR 1.75 [95% CI 1.07, 2.85], p=0.02) but little evidence of association with other cancer endpoints (Table 2).